Flatiron Health’s Post

WATCH: In this short video, our chief innovation and technology officer, Sagran Moodley, discusses how Ontada is using technology, #RWD, and #RWR studies to innovate, disrupt, and transform cancer care. #OncologyTech #RWE

10 lessons learned from starting a new scientific editing program at a comprehensive cancer center (#1: Many faculty were not familiar with professional editing services.) Read more here: https://lnkd.in/eW_xPtff #CSEScienceEditor #scienceeditors #sciencepublishing

The FDA advocates for diversity plans for clinical trials, endorsing #realworlddata use to optimize and broaden eligibility criteria. This study, published today in NEJM Evidence, investigates how expanding inclusion criteria impacts the diversity of eligible patients with cancer. Hear from Maneet Kaur, PhD, MPH, Senior Quantitative Scientist about the study's inspiration and explore the full publication through the link: https://lnkd.in/es8aJB2e

The next NCI #SBIR informational webinar is only a week away. Register to receive a detailed overview on the funding opportunities and commercialization resources that cancer technology innovators can use to take their projects from lab to market: https://lnkd.in/eazfHpt4 

Curious about how collaboration fuels technological progress? Join our next #StandardsHub session on April 2 at 11 am. Hillary (Stires) Andrews from Friends of Cancer Research will explore the pivotal role collaboration plays in advancing science, policy, and regulation to accelerate the delivery of life-saving treatments to patients: https://bit.ly/3x0UI0z

Why do tumors respond — or don’t respond — to therapies? This is exactly what Prof. David Odde and team are trying to answer through modeling and simulation. The technology can also be used to test ideas for new cancer therapies and harness the power of personalized medicine. #cancerresearch #biomedicalengineering #bioengineering #drugdevelopment #bme #innovation #modelingandsimulation #modeling #UMN University of Minnesota College of Science and Engineering

This is worth 5 minutes. Alán Aspuru-Guzik of the Acceleration Consortium talks about how AI is revolutionizing drug discovery. "Yes, but Neil - how is AI revolutionizing the world of surfactants?", I hear you ask. Well - to learn all about that - you should be at our 14th World Surfactants Conference in Jersey City where members of the Acceleration Consortium and of Potion AI will be joined in a dedicated session by the great Craig Bettenhausen to get deep into this fascinating area. Book here: https://lnkd.in/eZcG5Xk3 #surfactants, #AI

Automated Text Messaging for Researchers at Universities, Cancer Centers and Hospitals https://buff.ly/46sFIV8 #automatedtextmessaging #textmessaging #textmessagingsoftware #clinicaltrials #clinicalresearch

Biological approaches have led to numerous advances in #cancer but integrating fields across #engineering & the physical sciences may accelerate cancer discovery and therapy. https://lnkd.in/ew8hJQYw

Lots of great studies this holiday season! 🎄 💡Here's an interesting one that popped up on my feed published in the American Society of Clinical Oncology (ASCO) journal and JCO Clinical Cancer Informatics (JCO CCI) evaluating the utility and privacy of synthetic #breastcancer #clinicaltrial data sets. ▪️ Synthetic data using sequential synthesis methods can act as a proxy for real clinical trial data sets, and simultaneously have low privacy risks. ▪️ This type of generative model can be one way to enable broader sharing of clinical trial data. #healthequity #syntheticdata #dataanalytics #dataquality #datavalidation